5-HT1A receptor knockout mouse as a genetic model of anxiety

European Journal of Pharmacology

Volumn 463, Issue 1-3, 2003, Pages 177-184

  Toth, Miklos ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

5 HT (5 hydroxytryptamine, serotin); 5 HT receptor; Anxiety; Benzodiazepine

Indexed keywords

BUSPIRONE; DIAZEPAM; FENCLONINE; FLESINOXAN; FLUNITRAZEPAM; FLUOXETINE; GEPIRONE; IPSAPIRONE; METIROSINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ANIMAL BEHAVIOR; ANXIETY; ANXIETY DISORDER; AVOIDANCE BEHAVIOR; DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; ELECTROPHYSIOLOGY; FEAR; GENE INACTIVATION; GENETIC MODEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KNOCKOUT MOUSE; LEARNING DISORDER; MENTAL DISEASE; NONHUMAN; OPEN FIELD BEHAVIOR; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REVIEW; RISK FACTOR; SEROTONIN RELEASE; STRESS;

EID: 0037470175     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01280-9     Document Type: Review

References (72)

1. 1A antagonists. Trends Neurosci. 9:1996;378-383.
2. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
3. 1A receptors without altering 5-HT autoreceptor sensitivity: an electrophysiological study in the rat brain. Synapse. 1:1987;225-232.
4. 1A autoreceptors. Neuropharmacology. 32:1993;527-534.
5. Bornstein R.A., Baker G.B., Douglass A.B. Depression and memory in major depressive disorder. J. Neuropsychiatry, Clin. Neurosci. 3:1991;78-80.
6. 1 binding sites in depressed suicides. Psychopharmacology (Berlin). 102:1990;544-548.
7. Crabbe J.C., Wahlsten D., Dudek B.C. Genetics of mouse behavior: interactions with laboratory environment. Science. 284:1999;1670-1672.
8. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology (Berlin). 121:1995;1-26.
9. Drevets W.C., Frank E., Price J.C., Kupfer D.J., Holt D., Greer P.J., Huang Y., Gautier C., Mathis C. PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry. 46:1999;1375-1387.
10. Eichenbaum H. The hippocampus and mechanisms of declarative memory. Behav. Brain Res. 103:1999;123-133.
11. Eichenbaum H., Dudchenko P., Wood E., Shapiro M., Tanila H. The hippocampus, memory, and place cells: is it spatial memory or a memory space? Neuron. 23:1999;209-226.
12. Fanselow M.S. Conditioned and unconditional components of post-shock freezing. Pavlovian J. Biol. Sci. 15:1980;177-182.
13. 2A receptor binding after chronic corticosterone associated with a behavioural indication of depression but not anxiety. Psychoneuroendocrinology. 22:1997;477-491.
14. 1A-receptors under psychosocial stress. J. Neurosci. 15:1995;7132-7140.
15. Graeff F.G., Silveira M.C., Nogueira R.L., Audi E.A., Oliveira R.M. Role of the amygdala and periaqueductal gray in anxiety and panic. Behav. Brain Res. 58:1993;123-131.
16. (1A) receptor KO mice. Biol. Psychiatry. 48:2000;1157-1163.
17. Gross C., Zhuang X., Stark K., Ramboz S., Oosting R., Kirby L., Santarelli L., Beck S., Hen R. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature. 416:2002;396-400.
18. 1A receptors. Baumgarten H.G., Gotner M. Serotoninergic Neurons and 5-HT Receptors in the CNS. 1997;238-268 Springer, Berlin.
19. Hashimoto S., Inoue T., Koyama T. Effects of conditioned fear stress on serotonin neurotransmission and freezing behavior in rats. Eur. J. Pharmacol. 378:1999;23-30.
20. 1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. Brain Res. 902:2001;11-17.
21. 1A receptor mutant mice. Proc. Natl. Acad. Sci. U. S. A. 95:1998;15049-15054.
22. 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study. J. Neurochem. 60:1993;776-779.
23. Hoyer D., Schoeffter P. 5-HT receptors: subtypes and second messengers. J. Recept. Res. 11:1991;197-214.
24. Ilsley J.E., Moffoot A.P., O'Carroll R.E. An analysis of memory dysfunction in major depression. J. Affect. Disord. 35:1995;1-9.
25. 1A receptors in the rat brain. Naunyn-Schmiedebergs Arch. Pharmacol. 347:1993;453-463.
26. 1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? J. Pharmacol. Exp. Ther. 272:1995;920-929.
27. Julius D. Molecular biology of serotonin receptors. Annu. Rev. Neurosci. 14:1991;335-360.
28. 1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur. J. Pharmacol. 138:1987;53-60.
29. Kirby L.G., Chou-Green J.M., Davis K., Lucki I. The effects of different stressors on extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid. Brain Res. 760:1997;218-230.
30. Knobelman D.A., Kung H.F., Lucki I. Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT (1A) and 5-HT (1B) receptors. J. Pharmacol. Exp. Ther. 292(3):2000;1111-1117. Mar.
31. Knobelman D.A., Hen R., Blendy J.A., Lucki I. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse. J. Pharmacol. Exp. Ther. 298:2001;1092-1100.
32. Knobelman D.A., Hen R., Lucki I. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. J. Pharmacol. Exp. Ther. 298:2001;1083-1091.
33. 1A autoreceptors of the dorsal and median raphe nuclei. J. Pharmacol. Exp. Ther. 269:1994;1268-1279.
34. 1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biol. Psychol. 28:1990;620-628.
35. 1A receptor sensitivity in depression and anxiety disorders: molecular mechanisms of neuroadaption. Clin. Neuropharmacol. 15(Suppl. 1 Pt. A):1992;208A-209A.
36. 1A receptor-effector system responsivity in panic disorder. Psychopharmacology (Berlin). 106:1992;111-117.
37. Lister R.G. The use of a plus maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
38. Lopez J.F., Chalmers D.T., Little K.Y., Watson S.J. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression. Biol. Psychiatry. 43:1998;547-573.
39. Lucki I., Singh A., Kreiss D.S. Antidepressant-like behavioral effects of serotonin receptor agonists. Neurosci. Biobehav. Rev. 18:1994;85-95.
40. MacDonald R.L., Olsen R.W. GABA A receptor channels. Annu. Rev. Neurosci. 17:1994;569-602.
41. Mann J.J. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior. Neuropsychopharmacology. 21:1999;99S-105S.
42. Mayorga A.J., Dalvi A., Page M.E., Zimov-Levinson S., Hen R., Lucki I. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J. Pharmacol. Exp. Ther. 298:2001;1101-1107.
43. McKittrick C.R., Blanchard D.C., Blanchard R.J., McEwen B.S., Sakai R.R. Serotonin receptor binding in a colony model of chronic social stress. Biol. Psychiatry. 37:1995;383-393.
44. Meijer O.C., Van Oosten R.V., De Kloet E.R. Elevated basal trough levels of corticosterone suppress hippocampal 5-hydroxytryptamine(1A) receptor expression in adrenally intact rats: implication for the pathogenesis of depression. Neuroscience. 80:1997;419-426.
45. Meltzer H.Y., Maes M. Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol. Psychiatry. 38:1995;450-457.
46. 1A receptors modulate the consolidation of learning in normal and cognitively impaired rats. Neurobiol. Learn. Mem. 71:1999;207-218.
47. Murphy D.L. Neuropsychiatric disorders and the multiple human brain serotonin receptor subtypes and subsystems. Neuropsychopharmacology. 3:1990;457-471.
48. Olivier B., Miczek K.A. Fear and anxiety: mechanisms, models and molecules. Dodman N., Shuster I. Psychopharmacology of Animal Behavior Disorders. 1999;105-121 Blackwell, London, UK.
49. 1A receptor and its ligands: structure and function. Prog. Drug Res. 52:1999;104-165.
50. (1A) receptor knockout mouse and anxiety. Behav. Pharmacol. 12:2001;439-450.
51. Parks C.L., Robinson P.S., Sibille E., Shenk T., Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc. Natl. Acad. Sci. U. S. A. 95:1998;10734-10739.
52. (1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission. J. Neurochem. 77:2001;607-617.
53. Pazos A., Palacios J.M. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res. 346:1985;205-230.
54. Plotsky P., Owens M., Nemeroff C. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am. 21:1998;293-307.
55. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229:1997;327-336.
56. Pritchett D.B., Sontheimer H., Shivers B.D., Ymer S., Kettenmann H., Schofield P.R., Seeburg P.H. Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology. Nature. 338:1989;582-585.
57. Ramboz S., Oosting R., Amara D.A., Kung H.F., Blier P., Mendelsohn M., Mann J.J., Brunner D., Hen R. Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14476-14481.
58. 1A receptors. Eur. J. Pharmacol. 435:2002;195-203.
59. Rodgers R.J., Johnson N.J.T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 52:1995;297-303.
60. Rush A.J., Weissenburger J., Vinson D.B., Giles D.E. Neuropsychological dysfunctions in unipolar nonpsychotic major depressions. J. Affect. Disord. 5:1983;281-287.
61. Sargent P.A., Kjaer K.H., Bench C.J., Rabiner E.A., Messa C., Meyer J., Gunn R.N., Grasby P.M., Cowen P.J. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch. Gen. Psychiatry. 57:2000;174-180.
62. Sarnyai Z., Sibille E.L., Pavlides C., Fenster R.J., McEwen B.S., Toth M. Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc. Natl. Acad. Sci. U. S. A. 97:2000;14731-14736.
63. Sibille E., Parks C., Robinson T., Sarnyai Z., Benjamin D., Baker H.et al. Neurobiology of anxiety in serotonin 1A receptor knock out mice. Soc. Neurosci. Abstr. 1998;308.5.
64. Sibille E., Pavlides C., Benke D., Toth M. Genetic inactivation of the Serotonin(1A) receptor in mice results in downregulation of major GABA(A) receptor alpha subunits, reduction of GABA(A) receptor binding, and benzodiazepine-resistant anxiety. J. Neurosci. 20:2000;2758-2765.
65. 1A receptor agonist ipsapirone in the rat: neurobiological correlates. Eur. J. Pharmacol. 240:1993;29-37.
66. 1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology. 27:1988;707-715.
67. Tarbuck A.F., Paykel E.S. Effects of major depression on the cognitive function of younger and older subjects. Psychol. Med. 25:1995;285-295.
68. Treit D., Fundytus M. Thigmotaxis as a test for anxiolytic activity in rats. Pharmacol. Biochem. Behav. 31:1988;959-962.
69. Vahabzadeh A., Fillenz M. Comparison of stress-induced changes in noradrenergic and serotonergic neurons in the rat hippocampus using microdialysis. Eur. J. Neurosci. 6:1994;1205-1212.
70. 2 receptors and transport sites for serotonin. Brain Res. 615:1993;87-94.
71. Wissink S., Meijer O., Pearce D., van Der Burg B., van Der Saag P.T. Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem. 275:2000;1321-1326.
72. Yehuda R., Teicher M.H., Trestman R.L., Levengood R.A., Siever L.J. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol. Psychiatry. 40:1996;79-88.